Delaware Commission Upholds Disqualification Of Dream Marie Over Amicar Positive

The disqualification of Dream Marie from the Obeah Stakes was upheld by a 3-2 vote of the Delaware Thoroughbred Racing Commission during its Nov. 17 meeting, reports The Racing Biz. The Matthew Williams trainee was disqualified from her June 9 victory after testing positive for Aminocaproic acid, or Amicar, which is not allowed in any amount on race day.

Aminocaproic acid is a “Class 4” drug that calls for a “Class C” penalty on the Association of Racing Commissioners International's Uniform Classification Guideline of Foreign Substances and Recommended Penalties.

Williams' legal team contended that the trainer administered Amicar a week out from the race for a workout, and that the amount remaining on race day was too small to have a pharmacological effect. There is no recommended withdrawal time for Amicar.

In addition, the team suggested that the recent dismissal of multiple Amicar rulings in Maryland should play into the Delaware Commission's decision.

Commissioner Henry Decker proposed a “hybrid solution” that would allow Dream Marie to retain her win but redistribute part of the purse money to the other finishers. Chairman Duncan Patterson argued that the “a positive is a positive is a positive,” and that the stewards had been fair.

The Delaware Commission narrowly voted (3-2) to uphold the stewards' decision to disqualify Dream Marie and not to fine Williams.

Read more at The Racing Biz.

The post Delaware Commission Upholds Disqualification Of Dream Marie Over Amicar Positive appeared first on Horse Racing News | Paulick Report.

Source of original post

Trainers In Maryland Warned About Use Of Amicar

The Maryland Thoroughbred Horsemen's Association has released a statement regarding the use of anti-bleeding medications for racehorses in training. Horsemen are encouraged to stop the use of these drugs immediately, particularly the use of aminocaproic acid, sold under the name Amicar.

Amicar and other anti-bleeding medications are used to prevent bleeding from horses that suffer from Exercise Induced Pulmonary Hemorrhage (EIPH).

Amicar and multiple other anti-bleeding medications were placed on the Prohibited List in 2013 under Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances.

These medications were placed on this list because they cannot be regulated by withdrawal time guidelines, and the medications have no timeline in which they can be used in which they might not trigger a positive test post-race.

Any trainer who uses these medications runs the risk of his or her horse coming back with a positive drug test post-race.

Read more here.

The post Trainers In Maryland Warned About Use Of Amicar appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights